A Retrospective Review of the Clinical Outcomes of Trastuzumab Deruxtecan (T-DXd) for the Treatment of Advanced HER2-positive Breast Cancer at the Mount Vernon Cancer Centre. Issue 6 (June 2023) - Bienz, M.; Malek, A.; Sidon, L.; Miles, D.